pubmed-article:16165710 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16165710 | lifeskim:mentions | umls-concept:C0221908 | lld:lifeskim |
pubmed-article:16165710 | lifeskim:mentions | umls-concept:C0043240 | lld:lifeskim |
pubmed-article:16165710 | lifeskim:mentions | umls-concept:C0021853 | lld:lifeskim |
pubmed-article:16165710 | lifeskim:mentions | umls-concept:C0127615 | lld:lifeskim |
pubmed-article:16165710 | lifeskim:mentions | umls-concept:C0033414 | lld:lifeskim |
pubmed-article:16165710 | lifeskim:mentions | umls-concept:C1533691 | lld:lifeskim |
pubmed-article:16165710 | lifeskim:mentions | umls-concept:C0441712 | lld:lifeskim |
pubmed-article:16165710 | pubmed:issue | 8 | lld:pubmed |
pubmed-article:16165710 | pubmed:dateCreated | 2005-9-16 | lld:pubmed |
pubmed-article:16165710 | pubmed:abstractText | Treatment with 5-aminosalicylic acid (5-ASA) derivatives is one of the main principles in the therapy of uncomplicated mild to moderate inflammatory bowel diseases (IBD). The beneficial effect of 5-ASA in the treatment of IBD is attributed to its anti-inflammatory and anti-oxidant properties within the inflamed gut. The aim of this study was to investigate whether 5-ASA also modulates intestinal epithelial wound repair in vitro. | lld:pubmed |
pubmed-article:16165710 | pubmed:language | eng | lld:pubmed |
pubmed-article:16165710 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16165710 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:16165710 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16165710 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16165710 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16165710 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16165710 | pubmed:month | Aug | lld:pubmed |
pubmed-article:16165710 | pubmed:issn | 0036-5521 | lld:pubmed |
pubmed-article:16165710 | pubmed:author | pubmed-author:WiedenmannBer... | lld:pubmed |
pubmed-article:16165710 | pubmed:author | pubmed-author:SturmAndreasA | lld:pubmed |
pubmed-article:16165710 | pubmed:author | pubmed-author:DignassAxel... | lld:pubmed |
pubmed-article:16165710 | pubmed:author | pubmed-author:BaumgartDanie... | lld:pubmed |
pubmed-article:16165710 | pubmed:author | pubmed-author:VierzigerKari... | lld:pubmed |
pubmed-article:16165710 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16165710 | pubmed:volume | 40 | lld:pubmed |
pubmed-article:16165710 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16165710 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16165710 | pubmed:pagination | 958-64 | lld:pubmed |
pubmed-article:16165710 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:16165710 | pubmed:meshHeading | pubmed-meshheading:16165710... | lld:pubmed |
pubmed-article:16165710 | pubmed:meshHeading | pubmed-meshheading:16165710... | lld:pubmed |
pubmed-article:16165710 | pubmed:meshHeading | pubmed-meshheading:16165710... | lld:pubmed |
pubmed-article:16165710 | pubmed:meshHeading | pubmed-meshheading:16165710... | lld:pubmed |
pubmed-article:16165710 | pubmed:meshHeading | pubmed-meshheading:16165710... | lld:pubmed |
pubmed-article:16165710 | pubmed:meshHeading | pubmed-meshheading:16165710... | lld:pubmed |
pubmed-article:16165710 | pubmed:meshHeading | pubmed-meshheading:16165710... | lld:pubmed |
pubmed-article:16165710 | pubmed:meshHeading | pubmed-meshheading:16165710... | lld:pubmed |
pubmed-article:16165710 | pubmed:meshHeading | pubmed-meshheading:16165710... | lld:pubmed |
pubmed-article:16165710 | pubmed:meshHeading | pubmed-meshheading:16165710... | lld:pubmed |
pubmed-article:16165710 | pubmed:meshHeading | pubmed-meshheading:16165710... | lld:pubmed |
pubmed-article:16165710 | pubmed:meshHeading | pubmed-meshheading:16165710... | lld:pubmed |
pubmed-article:16165710 | pubmed:meshHeading | pubmed-meshheading:16165710... | lld:pubmed |
pubmed-article:16165710 | pubmed:meshHeading | pubmed-meshheading:16165710... | lld:pubmed |
pubmed-article:16165710 | pubmed:year | 2005 | lld:pubmed |
pubmed-article:16165710 | pubmed:articleTitle | Mesalamine promotes intestinal epithelial wound healing in vitro through a TGF-beta-independent mechanism. | lld:pubmed |
pubmed-article:16165710 | pubmed:affiliation | Department of Medicine, Division of Hepatology & Gastroenterology, Charité Medical Center-Virchow Hospital, Medical School of the Humboldt-University of Berlin, Germany. | lld:pubmed |
pubmed-article:16165710 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16165710 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:16165710 | pubmed:publicationType | In Vitro | lld:pubmed |
pubmed-article:16165710 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16165710 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16165710 | lld:pubmed |